GB201009307D0 - Biological materials and uses thereof - Google Patents
Biological materials and uses thereofInfo
- Publication number
- GB201009307D0 GB201009307D0 GBGB1009307.8A GB201009307A GB201009307D0 GB 201009307 D0 GB201009307 D0 GB 201009307D0 GB 201009307 A GB201009307 A GB 201009307A GB 201009307 D0 GB201009307 D0 GB 201009307D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- biological materials
- biological
- materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000012620 biological material Substances 0.000 title 1
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1009307.8A GB201009307D0 (en) | 2010-06-03 | 2010-06-03 | Biological materials and uses thereof |
CN201080061963.2A CN102712695B (en) | 2009-12-18 | 2010-12-10 | Biological inhibitors of ROR1 capable of inducing cell death |
PCT/EP2010/007524 WO2011079902A2 (en) | 2009-12-18 | 2010-12-10 | Biological materials and uses thereof |
US13/516,925 US9150647B2 (en) | 2009-12-18 | 2010-12-10 | Biological inhibitors of ROR1 capable of inducing cell death |
DK10798728.1T DK2513146T3 (en) | 2009-12-18 | 2010-12-10 | Antibodies against ROR1 capable of inducing cell death by CLL |
EP10798728.1A EP2513146B1 (en) | 2009-12-18 | 2010-12-10 | Antibodies against ror1 capable of inducing cell death of cll |
ES10798728.1T ES2635316T3 (en) | 2009-12-18 | 2010-12-10 | Antibodies against ROR1 that can induce LLC cell death |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1009307.8A GB201009307D0 (en) | 2010-06-03 | 2010-06-03 | Biological materials and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201009307D0 true GB201009307D0 (en) | 2010-07-21 |
Family
ID=42471108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1009307.8A Ceased GB201009307D0 (en) | 2009-12-18 | 2010-06-03 | Biological materials and uses thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201009307D0 (en) |
-
2010
- 2010-06-03 GB GBGB1009307.8A patent/GB201009307D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL260794B (en) | Composite materials and uses thereof | |
GB201013989D0 (en) | Biological materials and methods of using the same | |
GB201011771D0 (en) | Biological material and particular uses thereof | |
IL222961A0 (en) | Novel dna-dinding proteins and uses thereof | |
RS56312B1 (en) | Bisaryl-bonded aryltriazolones and use thereof | |
SMT202100676T1 (en) | Anti-cd277 antibodies and uses thereof | |
IL223050A (en) | Substituted 5 -fluoro-1h- pyrazolopyridines and use thereof | |
ZA201208173B (en) | Peptices and their use | |
RS54992B1 (en) | Oligopeptidic compounds and uses thereof | |
IL207216A0 (en) | Biological materials and uses thereof | |
GB0904825D0 (en) | Biological materials and uses thereof | |
GB2477597B (en) | Disinfectant materials and methods | |
SI2406280T1 (en) | Biological materials and uses thereof | |
GB201002082D0 (en) | Biological material | |
GB0811362D0 (en) | Biological materials and uses thereof | |
GB0922143D0 (en) | Biological materials and uses thereof | |
GB201009307D0 (en) | Biological materials and uses thereof | |
GB0802980D0 (en) | Biological materials and uses thereof | |
GB201011770D0 (en) | Biological material and there uses thereof | |
GB201112000D0 (en) | Biological materials and uses thereof | |
GB201019361D0 (en) | Biosensor and uses thereof | |
GB201007768D0 (en) | Composite materials and uses thereof | |
GB201014319D0 (en) | Compounds and uses thereof | |
GB0802075D0 (en) | Biological materials and uses thereof | |
GB0808956D0 (en) | biological materials and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |